SUVRETTA CAPITAL MANAGEMENT, LLC - THERAPEUTICS ACQUISITION COR ownership

Quarter-by-quarter ownership
SUVRETTA CAPITAL MANAGEMENT, LLC ownership history of THERAPEUTICS ACQUISITION COR
ValueSharesWeighting
Q2 2021$21,017,000
+85.8%
2,045,600
+90.1%
0.31%
+88.0%
Q1 2021$11,309,0001,076,0000.17%
Other shareholders
THERAPEUTICS ACQUISITION COR shareholders Q3 2021
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 864,214$8,875,0003.65%
BVF INC/IL 2,772,226$28,498,0001.07%
Johnson & Johnson Innovation - JJDC, Inc. 1,000,000$10,274,0001.05%
Boxer Capital, LLC 2,500,000$25,675,0000.91%
BERYLSON CAPITAL PARTNERS, LLC 386,221$3,968,0000.88%
SPHERA FUNDS MANAGEMENT LTD. 1,009,497$10,378,0000.70%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,045,600$21,017,0000.31%
FIRETHORN WEALTH PARTNERS, LLC 29,485$303,0000.25%
RA Capital Management 1,098,318$11,284,0000.18%
FARALLON CAPITAL MANAGEMENT LLC 2,400,000$24,672,0000.10%
View complete list of THERAPEUTICS ACQUISITION COR shareholders